Walleye Capital’s Aspen Aerogels ASPN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-834
Closed -$2.81K 4369
2025
Q4
$2.36K Buy
+834
New +$4.3K ﹤0.01% 4368
2025
Q1
Sell
-80,805
Closed -$779K 4236
2024
Q4
$960K Buy
80,805
+69,225
+598% +$1.18M ﹤0.01% 2426
2024
Q3
$321K Sell
11,580
-57,758
-83% -$1.45M ﹤0.01% 3677
2024
Q2
$1.65M Buy
+69,338
New +$1.63M ﹤0.01% 2290
2023
Q2
Sell
-79,912
Closed -$595K 4295
2023
Q1
$595K Buy
+79,912
New +$794K 0.01% 1568
2022
Q4
Sell
-165,502
Closed -$1.53M 3167
2022
Q3
$1.53M Buy
165,502
+29,331
+22% +$355K 0.03% 697
2022
Q2
$1.34M Buy
+136,171
New +$2.75M 0.04% 500
2022
Q1
Sell
-13,949
Closed -$695K 2277
2021
Q4
$695K Buy
+13,949
New +$735K 0.02% 787

Other funds holding ASPN

Walleye Capital's ASPN Position: Q1 2026 in Review

Walleye Capital sold out of Aspen Aerogels (ASPN) in Q1 2026, closing a stake of 834 shares — an estimated $2.81K sold.

Walleye Capital first reported a position in ASPN in Q4 2021 and held it in 8 quarters. The position peaked at $1.65M in Q2 2024. 166 funds tracked by Wall St. Rank hold ASPN as of Q1 2026.

  • Walleye Capital reported no remaining Aspen Aerogels position as of Q1 2026 after selling out during the quarter.
  • Walleye Capital sold 834 Aspen Aerogels shares in Q1 2026, an estimated $2.81K.
  • Walleye Capital first reported a position in Aspen Aerogels in Q4 2021 and held it in 8 quarters.
  • Walleye Capital's Aspen Aerogels position peaked at $1.65M in Q2 2024.
  • 166 funds tracked by Wall St. Rank held Aspen Aerogels as of Q1 2026.

Based on Walleye Capital's 13F filing for Q1 2026, filed 11 May 2026.